VSVagner Rodrigues Santos

Vagner Rodrigues Santos

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Vagner Rodrigues Santos has a total of 126 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Efficacy of propolis varnish in reducing Streptococcus mutans counts

    by Mariana Passos De Luca, Pablo Silveira Santos, Frederico Marianetti Soriani, Vagner Rodrigues Santos

    Aim: To evaluate the efficacy of experimental propolis varnish containing 15% green propolis in reducing Streptococcus mutans (SM) from saliva and dental biofilms. Methods: Patients aged 8–11 years were recruited from a preventive program. After prophylaxis, propolis varnish was applied to collect saliva and biofilm samples at regular times (baseline/T0, 2nd day/T1, 3rd day/T2, 4th day/T3, 5th day/T4, 10th day/T5, 15th day/T6, and 30th day/T7). After each sampling, stimulated whole saliva was homogenized for 30 s, and tenfold serial dilutions in saline were plated on mitis-salivarius-bacitracin (MSB) agar and incubated at 37°C for 48 h. Colonies with typical morphology were counted, and the number of colony-forming units (CFU)/mL was compared via an independent sample t test. For quantitative real-time PCR (qPCR), the data were statistically analysed via one-way ANOVA with the Holm‒Sidak post hoc test. Results: There was a significant difference in salivary SM levels between T0/T1 (baseline/2nd day) and T1/T7 (2nd day/30th day), but no difference was observed from the 3rd day onwards. The qPCR results also revealed a decrease in the number of SMs in the biofilm in the first days after varnish application. Conclusions: A single application of green propolis varnish reduced SM in saliva and biofilms for three days. Whether these findings affect the incidence of caries needs to be confirmed through studies, which may improve the original formulation (International Clinical Trials Registry Platform registration code: NCT02052973).


  • Open Access

    Oral candidiasis identification and profile of Candida in Brazilian patients undergoing radiotherapy in the head and neck region and in patients with removable complete dentures

    by Mara Cristina Lopes Amorim, Susana Johann, Carlos Augusto Rosa, Evandro Neves Abdo, Vagner Rodrigues Santos

    Introduction: Candidiasis is the most common oral fungal infection in humans affecting mainly people who are debilitated or immunocompromised patients, such as those irradiated for head and neck cancer. Pourpose: Identifing Candida species in head and neck irradiated patients and in those with total removable dental prosthesis by three microbiological methods. Material and Methods: Samples were collected with disposable sterile swabs of twenty-seven patients through exfoliative cytology. The Sabouraud media containing the inoculum were left in an aerobic environment at 36oC during 24 hours. Thus, yeasts were taken to the Laboratory of Taxonomy, Biodiversity and Biotechnology of Fungi to have the respective test for Candida identification with Candifast®, CHROMagar® and PCR EI1®. Results: The pseudomembranous clinical candidosis was more prevalent in Group 1, while the denture stomatitis was the most frequent clinical form in Group 2. There were differences in identification when comparing the three methods. On the other hand, PCR was faster and more effective when compared with CHROMagar, followed by Candifast®. PCR (EI1 and NLI/NL4) identified in Group 1 as C. albicans (37.1%), C. tropicalis (55%), (7.4%) C. krusei. In Group 2 PCR allowed the identification of 68% C. albicans, 20% as C. tropicalis, 8% as C. glabrata and 4% C. parapsilosis. Conclusion: The Candifast® Kit was found to be defective in the identification of several species of Candida, as compared to the molecular identification method used (PCR EI1 and PCR NL1 / NL4). CHROMagar® Candida medium was a good method for the presumptive identification of Candida species.

  • Open Access

    Grade IV oral mucositis treatment with Brazilian green propolis mucoadherent gel

    by Diogo Alvarenga Silva, Patrícia Carlos Caldeira, Silvia Ferreira de Sousa, Vagner Rodrigues Santos

    Green propolis is collected by Apis mellifera from the flowers and buds of Baccharis dracunculifolia. It has several chemical compounds that confer anti-inflammatory, antimicrobial, healing, and antioxidant biological activities. To report a series of clinical cases in the treatment of oral mucositis (OM) in patients with cancer undergoing radiotherapy in the head and neck region. Rapid treatment of OM means restoring quality of life to patients and lowering the cost of cancer treatment for public health. There male patients with oral carcinoma undergoing radiotherapy treatment were followed between August 2018 and April 2019. The patients presented themselves to the clinics in the Faculty of Dentistry of Federal University of Minas Gerais with erythematous and ulcerated coalescing lesions with purulent fibrin pseudomembranes in the oral mucosa, classified as grade IV OM according to the World Health Organization. The patients complained about the inability to eat, drink, and speak, which caused the radiotherapy interruption. After completing the clinical forms, anamnesis, and proper oral hygiene of each patient, a mucoadherent gel containing 5% propolis was prescribed for daily use, with a 3 time-a-day application every 8 h. After 7 days of use, there was an 80% lesion reduction, with total remission after 15 days of its application. The rapid response with total remission of lesions seems to be related to the chemical composition of propolis. Clinical and cellphone monitoring of patients, weekly and daily, respectively, were essential for successful treatment. The patients were monitored for one year, being encouraged to make constant use of the gel to control hyposalivation caused by changes in the salivary glands during radiotherapy.


  • Open Access

    Anti-Inflammatory, Antimicrobial, Antioxidant and Photoprotective Investigation of Red Propolis Extract as Sunscreen Formulation in Polawax Cream

    by Thalita Marcolan Valverde, Bruna Nayane Goncalves de Souza Soares, Andréa Mendes Do Nascimento, Ângela Leão Andrade, Lucas Resende Dutra Sousa, Paula Melo de Abreu Vieira, Vagner Rodrigues Santos, Janaína Brandão Seibert, Tatiane Cristine Silva de Almeida, Caio Fabrini Rodrigues, et al.

    Many activities have been described for propolis, including, antiviral, antibacterial, antifungal, anti-inflammatory, immunoregulatory, antioxidant and wound healing properties. Recently, propolis has been highlighted due to its potential application in the pharmaceutical and cosmetic industries, motivating a better understanding of its antioxidant and anti-inflammatory activities. Propolis and its main polyphenolic compounds presented high antioxidant activity, and effectiveness as broad spectrum UVB and UVA photoprotection sunscreens. Through a qualitative phytochemical screening, the ethanolic red propolis extracts (EEPV) (70% at room temperature and 70% at a hot temperature) presented a positive result for flavonoids and terpenoids. It presented an antioxidant activity for reducing 50% of DPPH of 17 and 12 μg/mL for extraction at room temperature and at a hot temperature, respectively. The UPLC-QTOF-MS/MS analysis allowed the annotation of 40 substances for EEPV-Heated and 42 substances for EEPV-Room Temperature. The IC50 results of the ABTS scavenging activity was 4.7 μg/mL for both extractions, at room temperature and at a hot temperature. Additionally, we also evaluated the cytotoxic profile of propolis extracts against macrophage (RAW 264.7 cells) and keratinocytes (HaCaT cells), which showed non-cytotoxic doses in cell viability assays even after a long period of exposure. In addition, propolis extracts showed antibacterial activity for Gram-positive bacteria (Staphylococcus aureus and Staphylococcus epidermidis), demonstrating potential biological activity for the creation of formulations aimed at disease control and prevention.


  • Open Access

    Effects of Brazilian green propolis glycolic solutions against bacterial biofilm on elastomers used in maxillofacial prostheses

    by Rubens Signoretti Oliveira Silva, Fernanda Faria Rocha, José Alcides Almeida de Arruda, Isadora França Vieira da Silva, Cláudia Lopes Brilhante Bhering, Vagner Rodrigues Santos, Amália Moreno

    Maxillofacial prostheses are among the modalities of prosthetic rehabilitation but the disinfectant solutions for their cleaning have been barely explored. The purpose of the present study was to evaluate the antibacterial effects of a Brazilian green propolis glycolic (PGL) solution on the removal of biofilm from the surface of two maxillofacial elastomers (room temperature vulcanization [RTV] and high consistency silicone rubber [HCR]). A total of 42 specimens (3×10 mm) were made with these two elastomers and Staphylococcus aureus was allowed to grow for 24 hours on the surface of the biomaterials. Specimens (n=3) were randomly allocated to the following treatment groups by immersion for 15 minutes: 0.9% saline solution; 2% chlorhexidine gluconate (CHX); 11%, 16% and 20% PGL; and Daro Brand® antimicrobial liquid agent and antibacterial gel soap. Quantitative assessment was performed by counting the number of colony-forming units (CFU). Two-way ANOVA was employed for data analysis. Specimens of both maxillofacial elastomers treated with PGL solutions at concentrations of 11%, 16% and 20%, as well as 2% CHX, did not reveal CFU/mL of the S. aureus strain, indicating the broad spectrum of antibiofilm action of these disinfectant solutions. In addition, the Daro Brand® antimicrobial liquid agent showed lower CFU/mL in both maxillofacial elastomers compared to the Daro Brand® gel soap and 0.9% saline solution. Therefore, disinfection with PGL solutions is effective and might be considered to be a promising alternative in eliminating the S. aureus biofilm from specimens of maxillofacial elastomers by immersion for 15 minutes.


  • Open Access

    Influência de tensoativo na liberação de própolis de cimentos ionoméricos modificados em diferentes períodos de tempo.

    by Samara Tonholo Medeiros, Stéfane Edne Souza, Vinícius De Magalhães Barros, Ricardo Rodrigues Vaz, Vagner Rodrigues Santos, Walison Arthuso Vasconcellos

    Objetivo: O objetivo deste estudo foi avaliar in vitro a influência de um tensoativo na liberação de própolis de um cimento ionomérico modificado, em diferentes períodos de tempo. Métodos: Vinte corpos-de-prova foram confeccionados e divididos em dois grupos, sendo que no grupo A foi utilizado o pó modificado e o líquido do ionômero e no grupo B além do pó modificado e o líquido foi adicionado um tensoativo (álcool 50%). A liberação foi mensurada nos tempos de 1h, 2h,4h, 24h, 7 dias, 15 dias e 30 dias através de um espectrofotômetro. As mensurações foram realizadas no comprimento de 300nm, e os resultados submetidos à análise de variância (p=0,05). Resultados: Os resultados apontaram que a liberação foi significativamente maior nos tempos de 24 horas (média de 166,6µg para o grupo A e 118,9µg para grupo B) e 7 dias (Grupo A:134,4µg; Grupo B:168µg), quando comparado aos demais períodos estudados. Conclusão: A própolis incorporada ao cimento ionomérico modificado foi liberada, sendo sua liberação influenciada pelo período de liberação, e não havendo diferença significante em função do uso ou não de tensoativo.

  • Open Access

    Photoprotective activity and increase of SPF in sunscreen formulation using lyophilized red propolis extracts from Alagoas

    by Wanessa A. da S. Almeida, Amanda dos Santos Antunes, Ricardo G. Penido, Helen S. da G. Correa, Andrea M. Do Nascimento, Ângela L. Andrade, Vagner R. Santos, Thiago Cazati, Tatiane Roquete Amparo, Gustavo Henrique Bianco de Souza, et al.


  • Open Access

    Antifungal Activity of Brazilian Medicinal Plants against Candida Species

    by Vagner Rodrigues Santos, Elizete Maria Rita Pereira

    Due to the resistance of Candida sp. to the usual antifungal, the demand for active principles found in the plants has been the target of diverse studies around the world. There are few in vivo and human studies on the antifungal activity of medicinal plants in the mouth. Native and imported medicinal plants, used by the Brazilian population for traditional medicine use, are the subject of study in this chapter. Thirty-eight Brazilian plants were related to information on species, family, name, used part, and medical indication of popular use. All the species mentioned had their extracts tested in vitro against C. albicans, C. tropicalis, C. krusei, C. parapsilosis, among other species that occur more frequently in the mouth. In the articles consulted, there is a great variation in Candida species tested and in minimum inhibitory concentration. The in vitro studies serve as information for the continuity of studies on the best performing plants, validate the popular belief about the use, and provide subsidies for the development of new products that are effective in the control of oral and systemic candidiasis and that are cheap and accessible for the population.


  • Oral paracoccidioidomycosis: Retrospective analysis of 55 Brazilian patients

    by Aline Heloísa Trindade, Henrique Côrtes Meira, Igor Figueiredo Pereira, Julio César Tanos de Lacerda, Ricardo Alves de Mesquita, Vagner Rodrigues Santos

    Summary: Paracoccidioidomycosis (PCM) is a rare fungal infection in the world, but endemic and acquired exclusively in Latin America, with the highest prevalence in South America and Brazil, particularly. Changes in oral cavity are common and constitute the first clinical manifestation in many patients. The aim of this study was to describe the prevalence of oral PCM and analyse the profile of the disease and patients. Retrospective research, consisting of information present in the medical records in the period 1998‐2015, whose histopathological diagnosis was oral PCM. Fifty‐five oral PCM cases were confirmed. Of these patients, 90.9% were males and 9.1% were females. The average age was 49.66 years and the most reported occupation was rural workers. The painful symptomatology was present in 61.82% of patients. Erythematous lesions were predominant in 73% of them. In single lesions (22 cases), the most common locations were jugal mucosa and tongue. In multiple involvement (30 cases), the most affected regions were lips, jugal mucosa and alveolar ridge. Epidemiology of PCM, was similar to several other studies, especially in Brazil. This is the most important fungal infection in Latin America and the recognition of oral lesions is extremely important, as is often the first and in many cases the only manifestation of the disease.